Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Neuronetics, Inc.

Empa Elektronik Sanayi ve Ticaret A.S. ( ($TR:EMPAE) ) has shared an announcement. Turkey’s Capital Markets Board has updated its list of non-publi...

CMB Reclassifies Restricted Share Classes, Empa Elektronik Included in Non-Tradable List

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB) w...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	STIM	$2.82	-2.08%	573.22K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	STIM	$2.82	-2.1%	573.22K
3
4
5
6

STIM

Get Neuronetics, Inc. Data in Excel

Get Neuronetics, Inc. Data in Excel